Regenerative medicine of the highest safety and efficacy requires the expertise of scientists and a dedicated facility for culturing human cells. The high-quality service of regenerative medicine at Tokyo Clinic is supported by the collaboration with Biotherapy Institute of Japan, Inc. (BIJ), a world-renowned company for culturing human cells. BIJ operates cell processing facilities that have been certified by the Ministry of Health, Labor and Welfare, Japan.
The certification process is officially ruled under the Regenerative Medicine Safety Assurance Act and requires the detailed evaluation by the Pharmaceuticals and Medical Devices Agency (PMDA), an independent administrative institution to ensure the safety and efficacy of medicine and medical equipment. BIJ has a proven track record in cell culture business and hold various patents on cell culture technologies.
BIJ conducts thorough quality management and safety inspection of all products to ensure the highest quality of regenerative medicine products.